Gloria Coronado, PhD, is an epidemiologist who champions affordable, long-term solutions to health disparity issues. She leads a well-funded research portfolio that inspires health system leaders to make sensible, evidence-informed choices to engage hard-to-reach populations in life-saving preventive behaviors.
Dr. Coronado has developed several innovative, cost-effective interventions to improve rates of participation in cancer screening among patients served by community health centers. Her work has led to successful partnerships with large health plans, state institutions, and community clinics. She currently directs or co-directs three programs that employ systems-based approaches to raise the rates of colorectal cancer screening and follow-up in health plans and clinics in Washington, Oregon, and California.
Dr. Coronado’s research uses existing health system data and population segmentation approaches to proactively deliver outreach to patients who need it the most; her research strives to promote health care efficiency while advancing equity.
Dr. Coronado’s team specializes in applying patient-engagement strategies to develop culturally relevant health education material. Materials developed by her team (English- and Spanish-language patient-facing materials, e.g. fact sheets, videos, training modules) have been disseminated to hundreds of health systems and community organizations across the United States.
Dr. Coronado came to the Center for Health Research from the Cancer Prevention Program at the Fred Hutchinson Cancer Research Center, where she led a training program that prepared diverse undergraduate and postbaccalaureate students to conduct cancer research.
Over the course of her career, Dr. Coronado has served as the principal investigator, co-investigator or co-principal investigator on over 35 federally funded grants; she has authored or co-authored over 180 peer-reviewed manuscripts. She currently serves as a member of the National Academies of Science, Engineering and Medicine Committee on Improving the Representation of Women and Minorities in Clinical Trials and Research. She is a member of the Scientific Advisory Board for the National Cancer Institute.
Dr. Coronado received her PhD in epidemiology from the University of Washington and then was a research associate professor in the university’s Department of Epidemiology. She also received training at Stanford University.
Selected Current Studies
- Screening More Patients for CRC through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings—SMARTER CRC (NCI/Cancer Moonshot)
- Predicting and Addressing Colonoscopy Non-Adherence in Community Settings (NCI)
- Participatory Research to Advance Colorectal Cancer Prevention (NIMHD)
- Developing Faith-Based Colorectal Cancer Screening Messages for African Americans (CDC)
- Assessing Adherence to an Experimental Blood Test for Colorectal Cancer Detection (Guardant Health)
- Colonoscopy Versus Stool-Based Testing for Older Adults with a History of Colon Polyps (COOP Trial; PCORI)
- Assessing the Long-Term Impacts of the COVID-19 Pandemic on Disparities in Cancer Screening and Follow-Up (NCI)
- NCI Community Oncology Research Program Community Sites (NCORP; NCI)
- Coronado GD, Kihn-Stang A, Slaughter MT, Petrik AF, Thompson JH, Rivelli JS, Jimenez R, Gibbs J, Yadav N, Mummadi RR. Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process. BMC Gastroenterol. 2021 Sep 28;21(1):356. Epub 2021-09-28. PMID 34583638
- Coronado GD, Schneider JL, Green BB, Coury JK, Schwartz MR, Kulkarni-Sharma Y, Baldwin LM. Health plan adaptations to a mailed outreach program for colorectal cancer screening among Medicaid and Medicare enrollees: the BeneFIT study. Implement Sci. 2020 Sep 15;15(1):77. Epub 2020-09-15. PMID 32933525
- Coronado GD, Rawlings AM, Petrik AF, Slaughter M, Johnson ES, Hannon PA, Cole A, Vu T, Mummadi RR. Precision patient navigation to improve rates of follow-up colonoscopy, an individual randomized effectiveness trial. Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. PMID 34583969
- Coronado GD, Nyongesa DB, Petrik AF, Thompson JH, Escaron AL, Younger B, Harbison S, Leo MC. Randomized Controlled Trial of Advance Notification Phone Calls vs Text Messages Prior to Mailed Fecal Test Outreach. Clin Gastroenterol Hepatol. 2020 Jul 30. PMID 32739569
- Coronado GD. Sustainable infrastructure and risk stratification are needed to appropriately deliver colorectal cancer screening globally. Cancer. 2022 Jan 05. PMID 34985770
- Coronado GD, Nielson CM, Keast EM, Petrik AF, Suls JM. The influence of multi-morbidities on colorectal cancer screening recommendations and completion. Cancer Causes Control. 2021 Mar 09. PMID 33687606
- Coronado GD. Who Is Reached With Clinic In-Reach and Outreach Strategies to Promote Colorectal Cancer Screening? Am J Public Health. 2020 Apr;110(4):437-439. PMID 32159997